This proved that the spliced gp100mel47–52/40–42 peptide identified by applying SpliceMet in in vitro experiments represented a natural tumor epitope produced from the full-length gp100mel membrane protein and was presented on the surface of gp100mel/HLA-A*03:01+ patient-derived melanoma cells. The gene discussed is HLA-A; the disease is neoplasm.